{"schema_version":"secwatch.filing_event.v1","accession":"0000849146-24-000039","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.136766+00:00","generated_at":"2026-06-03T22:39:05.366285+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"LifeVantage enters $5M revolving credit facility with Bank of America, matures 2027","bullets":["Revolving line of credit up to $5,000,000 with Bank of America; interest at Term SOFR + 2.00% (floor 0.00%).","Facility matures April 12, 2027; monthly interest payments starting May 31, 2024; principal due at maturity.","Obligations secured by substantially all assets of LifeVantage and guaranteed by subsidiary Lifeline Nutraceuticals Corporation.","Includes up to $1,000,000 sublimit for stand-by letters of credit; 2.00% p.a. fee on undrawn amounts.","New facility replaces prior revolving credit agreement with Zions Bancorporation, which was discharged concurrently."],"urls":{"canonical":"https://secwatch.observer/filing/0000849146-24-000039","json":"https://secwatch.observer/filing/0000849146-24-000039.json","markdown":"https://secwatch.observer/filing/0000849146-24-000039.md","text":"https://secwatch.observer/filing/0000849146-24-000039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/0000849146-24-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/lfvn-20240412.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:39:05.366285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba8b4dff0ff914472f321f18da7d30d303fd7ce6","claim":"Lifevantage Corp incurred revolving credit of $5,000,000 with Bank of America, N.A. at the greater of the Term SOFR Daily Floating Rate or 0.00%, plus 2.00% maturing April 12, 2027.","evidence_excerpt":"The Loan Agreement provides for a revolving line of credit in aggregate principal amount not to exceed $5,000,000 (the \"Line of Credit\").","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/0000849146-24-000039-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$5,000,000"},{"label":"Counterparty","value":"Bank of America, N.A."},{"label":"Rate","value":"the greater of the Term SOFR Daily Floating Rate or 0.00%, plus 2.00%"},{"label":"Maturity","value":"April 12, 2027"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"584cda9a3a9b24f51c0dbda391fdf3494be804c3","claim":"Lifevantage Corp entered into Loan Agreement with Bank of America, N.A. valued at $5,000,000 (effective 2024-04-12).","evidence_excerpt":"On April 12, 2024, LifeVantage Corporation (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with Bank of America, N.A., as Lender (the “Lender”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/849146/000084914624000039/0000849146-24-000039-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Bank of America, N.A."},{"label":"Value","value":"$5,000,000"},{"label":"Effective","value":"2024-04-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}